Wird geladen...
Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis
[Image: see text] Multiple effects on cancer cells are exerted by the peroxisome proliferator-activated receptor γ (PPAR-γ). Recent studies have shown that rosiglitazone, a synthetic PPAR-γ ligand, inhibits the growth of cells. This research was designed to assess the impact of rosiglitazone on diet...
Gespeichert in:
| Veröffentlicht in: | ACS Omega |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Chemical Society
2020
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7081392/ https://ncbi.nlm.nih.gov/pubmed/32201822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b04357 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|